The analysis of pharmaceutical products is an essential aspect for the safety of medicines and therefore of patients. Investigating the properties of active ingredients and secondary ingredients plays a central role in ensuring the intended effect.
Another important component of analytical studies of pharmaceutical products is stability over a specified storage period using so-called stability studies. For patient safety, it is also important to detect the slightest contamination from the production process or from interaction with the packaging using suitable, highly sensitive test methods before the products reach the market. For this purpose, it is usually necessary to develop and validate tailor-made analytical methods.
The laboratories in which analytical tests are carried out on approved pharmaceutical products are subject to the supervision of the Regional Therapeutic Products Inspectorate (RHI) or the Swiss licensing and supervisory authority Swissmedic. In addition to national approval, a number of other internationally valid quality assurance guidelines such as GMP (Good Manufacturing Practice) are required for this type of analytical service. In addition to compliance with these regulations, highly qualified scientific staff is an essential prerequisite for carrying out analytical services on pharmaceutical products.
